RHHVF - Roche Holding AG
NEXT EARNINGS:
Jul 23, 2026
EPS Est: $13.87
|
Rev Est: $40.7B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
Market Cap:
384.12B
Volume:
506
Avg Volume:
19,313
52 Week Range:
277-490.33
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.20
Last Dividend:
$10.97
Exchange:
OTC
Country:
CH
Employees:
103,249
IPO Date:
2009-02-13
EPS (TTM):
16.19
P/E Ratio:
20.23
Revenue (TTM):
61.55B
Total Assets:
100.75B
Total Debt:
34.45B
Cash & Equiv:
5.58B
Rev Growth (5Y):
1.1%
EPS Growth (5Y):
-0.6%
FCF Growth (5Y):
3.5%
ROCE:
26.5%
Debt/Equity:
1.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $8.60 | $10.83 | -20.6% | $38.6B | $39.2B | -1.6% |
| 2025-06-30 | $11.61 | $13.18 | -11.9% | $40.1B | $38.9B | +3.0% |
| 2024-12-31 | $2.77 | $9.25 | -70.1% | $34.8B | $33.9B | +2.8% |
| 2024-06-29 | $8.71 | $10.42 | -16.4% | $34.3B | $32.9B | +4.2% |
| 2023-12-31 | $6.34 | $10.07 | -37.0% | $34.9B | $34.8B | +0.3% |
| 2023-06-30 | $9.90 | $11.62 | -14.8% | $33.2B | $33.8B | -1.9% |
| 2022-12-31 | $5.26 | $9.49 | -44.6% | $33.5B | $33.5B | 0.0% |
| 2022-06-30 | $10.99 | $11.53 | -4.7% | $33.7B | $33.6B | +0.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 61.55B | 62.40B | 60.44B | 63.28B | 62.80B | 58.32B | 61.47B | 56.85B | 53.30B | 50.58B | 48.15B | 47.46B |
| Net Income | 12.89B | 8.28B | 11.50B | 12.42B | 13.93B | 14.29B | 13.50B | 10.50B | 8.63B | 9.58B | 8.86B | 9.33B |
| EPS | 16.19 | 10.39 | 14.40 | 15.53 | 16.39 | 16.72 | 15.77 | 12.30 | 10.12 | 11.24 | 10.41 | 10.99 |
| Total Assets | 100.75B | 101.80B | 90.47B | 88.15B | 92.32B | 86.14B | 83.09B | 78.52B | 76.68B | 76.82B | 75.76B | 75.64B |
| Total Debt | 34.45B | 36.35B | 30.78B | 26.54B | 32.55B | 15.41B | 15.58B | 18.77B | 18.96B | 22.36B | 23.25B | 25.71B |
| Cash & Equivalents | 5.58B | 6.97B | 5.38B | 4.99B | 6.85B | 5.73B | 6.08B | 6.68B | 4.72B | 4.16B | 3.73B | 3.74B |
| Operating Cash Flow | 17.84B | 20.09B | 16.09B | 18.41B | 20.98B | 18.57B | 22.39B | 19.98B | 18.02B | 15.00B | 15.25B | 15.93B |
| Free Cash Flow | 14.09B | 15.09B | 11.45B | 13.86B | 16.43B | 11.88B | 17.49B | 15.06B | 13.81B | 9.86B | 11.14B | 12.60B |
| FCF per Share | 17.70 | 18.80 | 14.25 | 17.33 | 19.33 | 13.89 | 20.43 | 17.63 | 16.19 | 11.57 | 13.09 | 14.84 |
| Book Value | 33.82B | 31.77B | 29.32B | 27.99B | 24.49B | 36.34B | 32.75B | 27.62B | 26.44B | 23.91B | 20.98B | 19.59B |
| Cash & ST Investments | 15.48B | 17.32B | 10.51B | 9.77B | 13.03B | 12.33B | 11.86B | 13.12B | 12.00B | 9.11B | 9.17B | 11.70B |
| ROC Equity | 0.38 | 0.26 | 0.39 | 0.44 | 0.57 | 0.39 | 0.41 | 0.38 | 0.33 | 0.40 | 0.42 | 0.48 |